1
|
Camps-Vilaro A, Subirana I, Ramos R, Cainzos-Achirica M, Tizon-Marcos H, Fito M, Degano IR, Marrugat J. Five-Year Changes in Inflammatory, Metabolic, and Oxidative Biomarkers and 10-Year Cardiovascular Disease Incidence: The REGICOR Cohort Study. Int J Mol Sci 2023; 24:ijms24097934. [PMID: 37175639 PMCID: PMC10178750 DOI: 10.3390/ijms24097934] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2023] [Revised: 04/18/2023] [Accepted: 04/20/2023] [Indexed: 05/15/2023] Open
Abstract
Ischemic cardiovascular diseases (CVD) originate from an imbalance between atherosclerotic plaque formation, instability, and endothelial healing dynamics. Our aim was to examine the relationship between 5-year changes in inflammatory, metabolic, and oxidative biomarkers and 10-year CVD incidence in a population without previous CVD. This was a prospective cohort study of individuals aged 35-74 years (n = 419) randomly selected from 5263 REGICOR participants without CVD recruited in 2005. Biomarkers were measured at baseline and in 2010. Participants were followed up until 2020 for a composite CVD endpoint including coronary artery disease, stroke, and peripheral artery disease. We used Cox regression to analyze the effect of biomarker levels on the occurrence of the composite endpoint, adjusted for traditional CVD risk factors and baseline levels of each biomarker. Individuals with elevated IL-6 or insulin after 5 years had a higher independent risk of CVD at 10 years, compared to those with lower levels. Each rise of 1 pg/mL of IL-6 or 10 pg/mL of insulin increased the 10-year risk of a CVD event by 32% and 2%, respectively. Compared to a model with traditional CVD risk factors only, the inclusion of IL-6 and insulin improved continuous reclassification by 51%. Elevated serum levels of IL-6 and insulin were associated with a higher risk of CVD at 10 years, independently of traditional CVD risk factors.
Collapse
Affiliation(s)
- Anna Camps-Vilaro
- REGICOR Study Group, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain
- CIBER of Cardiovascular Diseases (CIBERCV), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain
- Doctoral College, University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain
| | - Isaac Subirana
- REGICOR Study Group, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain
- CIBER of Cardiovascular Diseases (CIBERCV), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain
| | - Rafel Ramos
- Medical Science Department, School of Medicine, University of Girona, 17003 Girona, Spain
- Vascular Health Research Group, Institut Universitari per a la Recerca en Atenció Primària Jordi Gol i Gurina, 17002 Girona, Spain
- Girona Biomedical Research Institute, 17190 Girona, Spain
- Primary Care Services, Catalan Institute of Health, 17005 Girona, Spain
| | - Miguel Cainzos-Achirica
- Biomedical Research in Heart Diseases Group, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain
- Department of Cardiology, Hospital del Mar, 08003 Barcelona, Spain
| | - Helena Tizon-Marcos
- CIBER of Cardiovascular Diseases (CIBERCV), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain
- Biomedical Research in Heart Diseases Group, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain
- Department of Cardiology, Hospital del Mar, 08003 Barcelona, Spain
| | - Montse Fito
- Cardiovascular Risk and Nutrition Research Group, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain
- CIBER of Pathophysiology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain
| | - Irene R Degano
- REGICOR Study Group, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain
- CIBER of Cardiovascular Diseases (CIBERCV), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain
- Faculty of Medicine, University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain
| | - Jaume Marrugat
- REGICOR Study Group, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain
- CIBER of Cardiovascular Diseases (CIBERCV), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain
| |
Collapse
|
2
|
Kempf K, Röhling M, Kolb H, Martin S. Impact of a Low-Insulin-Stimulating Bread on Weight Development-A Real Life Randomised Controlled Trial. Nutrients 2023; 15. [PMID: 36904300 DOI: 10.3390/nu15051301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2023] [Revised: 03/02/2023] [Accepted: 03/04/2023] [Indexed: 03/09/2023] Open
Abstract
The impact on body weight development is usually analysed by comparing different diet types. Our approach was to change only one component, namely bread, common to most diets. In a single-centre triple-blind randomised controlled trial the effects of two different breads on body weight were analyzed without further lifestyle modification. Overweight adult volunteers (n = 80) were randomised 1:1 to exchange previously consumed breads for either a rye bread from milled whole grain (control) or a medium-carbohydrate, low-insulin-stimulating bread (intervention). Pre-tests demonstrated that the two bread types strongly differed in the glucose and insulin response elicited, but had similar energy content, texture and taste. The primary endpoint was the estimated treatment difference (ETD) in change of body weight after 3 months of treatment. Whereas body weight remained unchanged in the control group (-0.1 ± 2.0 kg), significant weight reduction was observed in the intervention group (-1.8 ± 2.9 kg), with an ETD of -1.7 ± 0.2 kg (p = 0.007), that was more pronounced in participants ≥ 55 years (-2.6 ± 3.3 kg), paralleled by significant reductions in body mass index and hip circumference. Moreover, in the intervention group, the percentage of participants with significant weight loss (≥1 kg) was twice as high as in the control group (p < 0.001). No other statistically significant changes in clinical or lifestyle parameters were noted. Simply exchanging a common insulinogenic bread for a low-insulin-stimulating bread demonstrates potential to induce weight loss in overweight persons, especially those at older age.
Collapse
|
3
|
Jiang M, Wu H, Zhang H, Su F, Cao L, Ren X, Tatenda G, Hu J, Cheng M, Wen Y. Association between the Triglyceride-Glucose Index and the Risk of Large Artery Atherosclerotic Stroke. Int J Clin Pract 2022; 2022:5191581. [PMID: 36304978 PMCID: PMC9578805 DOI: 10.1155/2022/5191581] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/25/2022] [Revised: 07/18/2022] [Accepted: 08/09/2022] [Indexed: 11/22/2022] Open
Abstract
The aim of this study is to evaluate the value of the triglyceride-glucose (TyG) index and the risk of large artery atherosclerotic (LAA) stroke. Information on general demographic and clinical characteristics, magnetic resonance angiography (MRA) examination, and blood biochemical index determination were obtained. Based on age stratification, three models to evaluate the odds ratio (OR) and the 95% confidence interval (95% CI) were employed to determine the correlation between the TyG index and the risk of LAA stroke. The most effective TyG index threshold in predicting a high risk of LAA stroke was identified using receiver operating characteristic (ROC) curve analysis. Logistic regression verified the association between the risk of LAA stroke and the TyG index. Both with and without age stratification, logistic regression analysis showed that the TyG index was a significant predictor of the occurrence of LAA stroke (P < 0.05). The maximum Youden index for determining a high risk of LAA stroke was found at a TyG index of 4.60. The area under the ROC curve was 0.69 (95% CI: 0.646-0.742, P < 0.05), sensitivity was 78.0%, and specificity was 63.4%. An elevated TyG index was remarkably associated with a high risk of LAA stroke.
Collapse
Affiliation(s)
- Mingfei Jiang
- Department of Diagnostics, Clinical School of Medicine, Wannan Medical College, Anhui, Wuhu 214002, China
| | - Huan Wu
- Department of Prevention Medical, School of Laboratory Medicine, Wannan Medical College, Anhui, Wuhu 214002, China
| | - Huiping Zhang
- Stroke Research Center, Department of Ultrasound, Ma'anshan People's Hospital, Anhui, Ma'anshan 243000, China
| | - Fan Su
- Department of Prevention Medical, School of Public Health, Wannan Medical College, Anhui, Wuhu 214002, China
| | - Lei Cao
- Department of Prevention Medical, School of Public Health, Wannan Medical College, Anhui, Wuhu 214002, China
| | - Xia Ren
- Department of Prevention Medical, School of Public Health, Wannan Medical College, Anhui, Wuhu 214002, China
| | - Grace Tatenda
- Department of Prevention Medical, School of Public Health, Wannan Medical College, Anhui, Wuhu 214002, China
| | - Jian Hu
- Department of Prevention Medical, School of Public Health, Wannan Medical College, Anhui, Wuhu 214002, China
| | - Mingjia Cheng
- Department of Diagnostics, Clinical School of Medicine, Wannan Medical College, Anhui, Wuhu 214002, China
| | - Yufeng Wen
- Department of Prevention Medical, School of Public Health, Wannan Medical College, Anhui, Wuhu 214002, China
| |
Collapse
|